0000899243-17-000226.txt : 20170104 0000899243-17-000226.hdr.sgml : 20170104 20170104160615 ACCESSION NUMBER: 0000899243-17-000226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARK IAN T CENTRAL INDEX KEY: 0001336504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 17505349 MAIL ADDRESS: STREET 1: SOLAZYME, INC. STREET 2: 225 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-03 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001336504 CLARK IAN T C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 1 0 0 0 Stock Option (Right to Buy) 14.43 2017-01-03 4 A 0 30000 0.00 A 2027-01-03 Common Stock 30000 30000 D The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from January 3, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Leiv Lea, as Attorney-in-Fact, for Ian T. Clark 2017-01-04